简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-02-28 19:20 Glucophage® Is the First Oral Diabetes Treatment Approved in Europe for Use During Pregnancy
2022-02-28 14:13 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
2022-02-28 11:20 GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer’s Disease
2022-02-25 19:56 rf IDEAS Announces Partnership with ID R&D to Add Market-Leading Biometric Solutions to its Offering
2022-02-25 09:17 New MAVENCLAD® Data at ACTRIMS Forum 2022 Show Favourable Efficacy Outcomes Versus Other Oral DMTs and Lower Occurrence of Further Relapses or Disability Progression
2022-02-23 19:32 rf IDEAS and Key Partners to Spotlight Healthcare IAM Solutions at HIMSS22
2022-02-23 18:43 Frazier Life Sciences Adds Highly Experienced Biopharmaceutical Executive to Team
2022-02-23 15:25 Exscientia to Present at Upcoming Investor Conferences in March
2022-02-23 09:25 Taro to Acquire Alchemee From Galderma
2022-02-22 19:01 Kaneka Eurogentec Announces the Successful Production of 25g of mRNA in One Batch
2022-02-22 09:42 FINEOS Announces Strong Adoption in 2021 of Updated Purpose-Built FINEOS Platform Among Tier-1&2 Employee Benefits Insurance Carrier Clients
2022-02-21 20:11 Karen L. Ling joins Galderma’s Advisory Committee
2022-02-21 15:37 Prestige BioPharma’s Herceptin Biosimilar, Tuznue®, Receives EU-GMP Certification
2022-02-21 14:16 Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
2022-02-21 09:17 European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations
2022-02-21 09:07 Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO® (avelumab) First-Line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma
2022-02-21 08:54 Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study1,2
2022-02-18 18:52 NEC OncoImmunity Publishes a Unique HLA Typing Technology That Discovers New HLA Alleles, and Tumor Specific HLA Alleles
2022-02-18 16:33 Capsa Healthcare Announces the Acquisition of Humanscale Healthcare
2022-02-18 10:02 BreastScreen Victoria Switches to Rimini Street Support for its Oracle Database Software, Unlocks Resources to Meet Increasing Service Demand

Business Wire Weibo

Press Releases

Latest Releases